NRXS (Neuraxis) Beginning Cash Position: $7.08 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NRXS Neuraxis Inc NRXS
42 GF Score
Price $6.15
GF Value $3.38
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Neuraxis Beginning Cash Position?

Neuraxis NRXS -1.91% 42 Beginning Cash Position is $7.08 Mil as of Jun. 2026. GuruFocus rates NRXS with a GF Score™ of 42/100 and a GF Value™ of $3.38 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Neuraxis's Beginning Cash Position for the quarter that ended in Jun. 2026 was $7.08 Mil.

Neuraxis's quarterly Beginning Cash Position increased from Dec. 2025 ($4.38 Mil) to Mar. 2026 ($4.97 Mil) and increased from Mar. 2026 ($4.97 Mil) to Jun. 2026 ($7.08 Mil).

Neuraxis's annual Beginning Cash Position declined from Dec. 2023 ($0.25 Mil) to Dec. 2024 ($0.08 Mil) but then increased from Dec. 2024 ($0.08 Mil) to Dec. 2025 ($3.70 Mil).

Neuraxis Beginning Cash Position Related Terms

Neuraxis Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Neuraxis's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuraxis Beginning Cash Position Chart

Neuraxis Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 1.90 0.32 0.25 0.08 3.70

Neuraxis Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 5.99 4.38 4.97 7.08
NRXS
42GF Score
Neuraxis Inc NRXS
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuraxis Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $7.08 Mil mean?
Neuraxis (NRXS) has a Beginning Cash Position of $7.08 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Neuraxis and its competitors.
Is Neuraxis' Beginning Cash Position too high?
Neuraxis' current Beginning Cash Position is $7.08 Mil. Overall, Neuraxis has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Neuraxis' Beginning Cash Position compare to CSBR and RLYB?
Neuraxis' Beginning Cash Position of $7.08 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Neuraxis and its competitors. Neuraxis's current Beginning Cash Position is $7.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuraxis stock overvalued right now?
Based on GuruFocus' analysis, Neuraxis (NRXS) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.38, compared to a current price of $6.15 — trading 82% above its estimated fair value. The current Beginning Cash Position is $7.08 Mil. Neuraxis' overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Neuraxis (NRXS), the current Beginning Cash Position is $7.08 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuraxis (NRXS) Overvalued in 2026?

Based on GuruFocus' analysis, Neuraxis stock appears to be overvalued. The current stock price of $6.15 is trading 82% above its estimated GF Value™ of $3.38. GuruFocus considers Neuraxis to be Significantly Overvalued.

Key valuation signals for NRXS:

  • Beginning Cash Position: $7.08 Mil
  • GF Value™: $3.38 vs. price of $6.15 (82% above fair value)
  • GF Score™: 42/100 with 6 warning signs

No single metric tells the full story. See the NRXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuraxis Business Description

Address 11611 North Meridian Street, Suite 330, Carmel, IN, USA, 46032
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
42GF Score

Get the complete analysis for NRXS

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.15
Price
$3.38
GF Value